C
Caihong Li
Researcher at Peking Union Medical College
Publications - 7
Citations - 3549
Caihong Li is an academic researcher from Peking Union Medical College. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 3, co-authored 4 publications receiving 924 citations.
Papers
More filters
Journal ArticleDOI
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
Chaolin Huang,Lixue Huang,Lixue Huang,Yeming Wang,Xia Li,Lili Ren,Xiaoying Gu,Xiaoying Gu,Liang Kang,Lili Guo,Min Liu,Xing Zhou,Jianfeng Luo,Zhenghui Huang,Shengjin Tu,Yue Zhao,Li Chen,Decui Xu,Yanping Li,Caihong Li,Lu Peng,Yong Mei Li,Wuxiang Xie,Dan Cui,Dan Cui,Lianhan Shang,Lianhan Shang,Guohui Fan,Guohui Fan,Jiuyang Xu,Geng Wang,Geng Wang,Ying Wang,Jingchuan Zhong,Chen Wang,Chen Wang,Jianwei Wang,Dingyu Zhang,Bin Cao +38 more
TL;DR: In this article, the authors describe the long-term health consequences of patients with COVID-19 who have been discharged from hospital and investigate the associated risk factors, in particular disease severity.
Journal ArticleDOI
1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study.
Lixue Huang,Qun Yao,Xiaoying Gu,Qiongya Wang,Lili Ren,Yeming Wang,Yeming Wang,Ping Hu,Li Guo,Min Liu,Jiuyang Xu,Xueyang Zhang,Yali Qu,Yanqing Fan,Xia Li,Caihong Li,Ting Yu,Jiaan Xia,Ming Wei,Li Chen,Yanping Li,Fan Xiao,Dan Liu,Jianwei Wang,Xianguang Wang,Bin Cao,Bin Cao,Bin Cao +27 more
TL;DR: Wang et al. as discussed by the authors conducted an ambidirectional cohort study of COVID-19 survivors who had been discharged from Jin Yin-tan Hospital (Wuhan, China) between Jan 7 and May 29, 2020.
Journal ArticleDOI
Antibody Responses and Clinical Outcomes in Adults Hospitalized With Severe Coronavirus Disease 2019 (COVID-19): A Post hoc Analysis of LOTUS China Trial.
Lili Ren,Guohui Fan,Guohui Fan,Wenjuan Wu,Li Guo,Yeming Wang,Yeming Wang,Xia Li,Conghui Wang,Xiaoying Gu,Xiaoying Gu,Caihong Li,Ying Wang,Geng Wang,Fei Zhou,Fei Zhou,Zhibo Liu,Zhibo Liu,Qing Ge,Yi Zhang,Yi Zhang,Hui Li,Hui Li,Lulu Zhang,Jiuyang Xu,Chen Wang,Chen Wang,Jianwei Wang,Bin Cao,Bin Cao +29 more
TL;DR: IgM, IgG against N, S and RBD and NAbs developed in most severe COVID-19 patients, and do not correlate clearly with clinical outcomes.
Journal ArticleDOI
Absolute reduction in peripheral regulatory T cells in patients with Graves' disease and post-treatment recovery.
Hai Yan Liu,Zhiyong Shi,Di-kun Fan,Sheng-Xiao Zhang,Lixiang Wu,Keyi Lu,Su-Yun Yang,Wan-Ting Li,Jing Kang,Caihong Li,Zhenguo Cheng,Y. Xue,Zhifang Wu,Xiao-feng Li,Sijin Li +14 more
TL;DR: In this article , the role of peripheral lymphocyte subpopulations in disease pathogenesis was explored, and the authors found that anti-thyroid drug therapy improved immune-mediated system disorders.
Journal ArticleDOI
Differential distribution and prognostic value of CD4+ T cell subsets before and after radioactive iodine therapy in differentiated thyroid cancer with varied curative outcomes
Zhiyong Shi,Shuang Zhang,Caihong Li,Di-kun Fan,Yan Xue,Zhenguo Cheng,Lixiang Wu,Keyi Lu,Zhifang Wu,Xiao-feng Li,Haiyan Liu,Sijin Li +11 more
TL;DR: In individuals with differentiated thyroid cancer, there is great variation in circulating immune cells, resulting in distinct treatment outcomes, and low absolute CD4+ T cell counts is linked to improved clinical outcomes as well as stronger adaptive and resilience capacities.